Published in Br J Clin Pharmacol on January 01, 1989
Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease. Cardiovasc Drugs Ther (1996) 0.77
The cellular basis of angiotensin converting enzyme mRNA expression in rat heart. Basic Res Cardiol (1996) 0.76
Temperature-induced cardiac remodeling in fish. J Exp Biol (2016) 0.75
Nipradilol, a new beta-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats. Heart Vessels (1997) 0.75
ACUTE HYPERTENSIVE VASCULAR DISEASE. 2. STUDIES ON VASCULAR REACTION PATTERNS AND PERMEABILITY CHANGES BY MEANS OF VITAL MICROSCOPY AND COLLOIDAL TRACER TECHNIQUE. Acta Pathol Microbiol Scand (1964) 2.20
Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res (1989) 2.14
Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res (1988) 2.02
Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J (1986) 1.61
Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res (1988) 1.48
Biochemical correlates of cardiac hypertrophy. IV. Observations on the cellular organization of growth during myocardial hypertrophy in the rat. Circ Res (1969) 1.47
Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. Br Heart J (1980) 1.44
The cellular pathology of experimental hypertension. IV. Evidence for increased vascular permeability. Am J Pathol (1969) 1.42
Myocardial DNA synthesis in experimental cardiac hypertrophy. Am J Physiol (1968) 1.39
Histopathological types of cardiac fibrosis in myocardial disease. J Pathol (1979) 1.38
Myocyte cell loss and myocyte hypertrophy in the aging rat heart. J Am Coll Cardiol (1986) 1.33
The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development. Circ Res (1979) 1.31
Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation (1987) 1.22
Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study. J Cardiovasc Pharmacol (1987) 1.14
Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats. Hypertension (1980) 1.08
Connective tissue content and myocardial stiffness in pressure overload hypertrophy. A combined study of morphologic, morphometric, biochemical, and mechanical parameters. Basic Res Cardiol (1983) 1.07
Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab Invest (1982) 1.06
Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium. Am J Pathol (1976) 1.06
Myocardial hypertrophy in Macaca fascicularis. Structural remodeling of the collagen matrix. Lab Invest (1987) 1.03
Correlations of fibrosis in endomyocardial biopsies from patients with aortic valve disease. Br Heart J (1980) 1.00
Diastolic function and myocardial structure in patients with myocardial hypertrophy. Special reference to normalized viscoelastic data. Circulation (1981) 0.99
Collagen in the normal and hypertrophied human ventricle. Cardiovasc Res (1977) 0.99
Structural vs. contractile protein remodeling and myocardial stiffness in hypertrophied rat left ventricle. J Mol Cell Cardiol (1988) 0.98
The cellular pathology of experimental hypertension. 7. Structure and permeability of the mesenteric vasculature in angiotensin-induced hypertension. Am J Pathol (1973) 0.97
Effects of cardiac hypertrophy secondary to hypertension on the coronary circulation. Am J Cardiol (1979) 0.93
Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade. Am J Cardiol (1984) 0.91
Cardiac performance in rats with renal hypertension. Circ Res (1976) 0.91
Morphometric analysis of collagen network and plasma perfused capillary bed in the myocardium of rats during evolution of cardiac hypertrophy. Basic Res Cardiol (1986) 0.91
Structural analysis of pressure versus volume overload hypertrophy of cat right ventricle. Am J Physiol (1985) 0.91
Biochemical correlates of cardiac hypertrophy. V. Labeling of collagen, myosin, and nuclear DNA during experimental myocardial hypertrophy in the rat. Circ Res (1972) 0.90
Protocollagen proline hydroxylase activity in rat heart during experimental cardiac hypertrophy. Circ Res (1972) 0.90
Collagen synthesis in development and reversal of cardiac hypertrophy in spontaneously hypertensive rats. Am J Cardiol (1979) 0.89
ACUTE HYPERTENSIVE VASCULAR DISEASE. 1. RELATION BETWEEN BLOOD PRESSURE CHANGES AND VASCULAR LESIONS IN DIFFERENT FORMS OF ACUTE HYPERTENSION. Acta Pathol Microbiol Scand (1964) 0.87
Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure. J Am Coll Cardiol (1989) 0.85
Consequences of intramyocardial arterial lesions in aortic valvular stenosis. Am J Pathol (1976) 0.83
Ultrastructural correlates of reduced cardiac function in human heart disease. Eur Heart J (1983) 0.83
The distribution of fibrosis in the left ventricle in congenital aortic stenosis and coarctation of the aorta. Circulation (1980) 0.83
Microvascular changes in the heart during chronic arterial hypertension. Circ Res (1988) 0.83
Correlation between myocardial structure and diastolic properties of the heart in chronic aortic valve disease: effects of corrective surgery. Am J Cardiol (1978) 0.81
Collagen metabolism in experimental cardiac hypertrophy in the rat and the effect of digitoxin treatment. Cardiovasc Res (1977) 0.80
Reversal of cardiac hypertrophy in renal hypertensive rats: medical vs. surgical therapy. Am J Physiol (1981) 0.80
Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats. Kidney Int (1986) 0.80
Ultrastructure of coronary arteries and myocardium in experimental hypertension. Exp Mol Pathol (1978) 0.78
Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation (1982) 3.23
Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol (1989) 2.95
Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents. Circulation (1989) 2.16
Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res (1989) 2.14
Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res (1993) 2.04
Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res (1988) 2.02
Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res (1990) 1.83
Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res (1991) 1.80
Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation (1990) 1.55
Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res (1988) 1.48
Patterns of myocardial fibrosis. J Mol Cell Cardiol (1989) 1.41
Myocardial remodeling and pathologic hypertrophy. Hosp Pract (Off Ed) (1991) 1.40
Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo. Am Heart J (1982) 1.39
Intraaortic balloon counterpulsation. A review of physiological principles, clinical results, and device safety. Ann Thorac Surg (1974) 1.20
Contribution of ventricular remodeling to pathogenesis of heart failure in rats. Am J Physiol Heart Circ Physiol (2001) 1.18
Cardiac myocyte necrosis induced by angiotensin II. Circ Res (1991) 1.13
Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload. Am J Physiol (1996) 1.13
Cardiopulmonary exercise testing in congestive heart failure. Am J Cardiol (1988) 1.13
Myocardial oxygen consumption: the role of wall force and shortening. Am J Physiol (1977) 1.07
Alterations in myocardial collagen content affect rat papillary muscle function. Am J Physiol Heart Circ Physiol (2000) 1.07
Contractile mechanics and interaction of the right and left ventricles. Am J Cardiol (1981) 1.07
Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab Invest (1982) 1.06
Cardiopulmonary exercise testing for evaluation of chronic cardiac failure. Am J Cardiol (1985) 1.06
Myocardial collagen remodeling in pressure overload hypertrophy. A case for interstitial heart disease. Am J Hypertens (1989) 1.06
Static anisotropic elastic properties of the aorta in living dogs. Circ Res (1969) 1.04
The pericardium and ventricular interaction, distensibility, and function. Am J Physiol (1980) 1.04
Fibrosis-induced reduction of endomyocardium in the rat after isoproterenol treatment. Circ Res (1989) 1.04
Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol (1995) 1.04
Myocardial hypertrophy in Macaca fascicularis. Structural remodeling of the collagen matrix. Lab Invest (1987) 1.03
Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension. Am J Cardiol (1990) 1.03
Static elastic properties of the left coronary circumflex artery and the common carotid artery in dogs. Circ Res (1970) 1.02
Determination of aerobic capacity and the severity of chronic cardiac and circulatory failure. Circulation (1987) 1.02
Structural vs. contractile protein remodeling and myocardial stiffness in hypertrophied rat left ventricle. J Mol Cell Cardiol (1988) 0.98
Inadequate collagen tethers in dilated cardiopathy. Am Heart J (1988) 0.98
Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation (1991) 0.97
Evidence and quantitation of left ventricular systolic resistance. Am J Physiol (1985) 0.96
Identification of high risk subsets of acute myocardial infarction. Derived from the myocardial infarction research units cooperative study data bank. Am J Cardiol (1978) 0.96
Amrinone in the treatment of chronic cardiac failure. J Am Coll Cardiol (1984) 0.95
Left ventricular dysfunction following acute myocardial infarction. A clinicopathologic and hemodynamic profile of shock and failure. Am J Med (1973) 0.95
Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure. Circulation (1982) 0.95
The contractile behavior of the heart and its functional coupling to the circulation. Prog Cardiovasc Dis (1982) 0.95
Factors influencing left ventricular shortening in isolated canine heart. Am J Physiol (1976) 0.94
Nonlinear anisotropic elastic properties of the canine aorta. Biophys J (1972) 0.94
Myocardial stiffness and reparative fibrosis following coronary embolisation in the rat. Cardiovasc Res (1989) 0.94
beta-blockade prevents sustained metalloproteinase activation and diastolic stiffening induced by angiotensin II combined with evolving cardiac dysfunction. Circ Res (2000) 0.94
Exercise testing in the evaluation of the patient with chronic cardiac failure. Am Rev Respir Dis (1984) 0.94
Left ventricular force-length relations of isovolumic and ejecting contractions. Am J Physiol (1976) 0.92
Structure and function of myocardial fibrillar collagen. Technol Health Care (1997) 0.91
Differential gene expression of extracellular matrix components in dilated cardiomyopathy. J Cell Biochem (1996) 0.90
Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension. Response to captopril. Am J Hypertens (1991) 0.90
Myocardial fibrosis in nonhuman primate with pressure overload hypertrophy. Am J Pathol (1989) 0.90
Lactate production during maximal and submaximal exercise in patients with chronic heart failure. J Am Coll Cardiol (1985) 0.89
Systolic mechanical properties of the left ventricle. Effects of volume and contractile state. Circ Res (1983) 0.89
Relation between mixed venous oxygen saturation and cardiac index. Nonlinearity and normalization for oxygen uptake and hemoglobin. Chest (1991) 0.88
Reactive and reparative fibrillar collagen remodelling in the hypertrophied rat left ventricle: two experimental models of myocardial fibrosis. Cardiovasc Res (1990) 0.88
Long-term vasodilator therapy with trimazosin in chronic cardiac failure. N Engl J Med (1980) 0.88
Physiologic versus pathologic hypertrophy and the pressure-overloaded myocardium. J Cardiovasc Pharmacol (1987) 0.88
The heart as a muscle--pump system and the concept of heart failure. Am Heart J (1979) 0.88
Collagen in the hypertrophied, pressure-overloaded myocardium. Circulation (1987) 0.87
A novel technique for isolating functional mast cells from the heart. Inflamm Res (2008) 0.87
The pressure-flow response of the pulmonary circulation in patients with heart failure and pulmonary vascular disease. Circulation (1985) 0.87
The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat. Am J Pathol (1989) 0.87
Cardiotonic agents in the management of chronic cardiac failure. Am Heart J (1982) 0.86
The dynamics of ventricular contraction: force, length, and shortening. Fed Proc (1980) 0.85
Catecholamine response to chronic ANG II infusion and its role in myocyte and coronary vascular damage. Am J Physiol (1995) 0.85
The metabolic demand and oxygen supply of the heart: physiologic and clinical considerations. Am J Cardiol (1979) 0.85
Application of heated-film velocity and shear probes to hemodynamic studies. Circ Res (1968) 0.84
The right ventricle: physiologic and pathophysiologic considerations. Crit Care Med (1983) 0.84
The effect of chronic pulmonary hypertension on left ventricular size, function, and interventricular septal motion. Am Heart J (1987) 0.84
Hemodynamic, ventilatory and metabolic effects of light isometric exercise in patients with chronic heart failure. J Am Coll Cardiol (1988) 0.84
Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat. J Mol Cell Cardiol (1999) 0.84
The calculation of the mean pressure gradient in aortic valvular stenosis: a simplified approach. Am Heart J (1975) 0.84
Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat. Cardiovasc Res (1995) 0.84
Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats. Basic Res Cardiol (1998) 0.83
Synergistic exacerbation of diastolic stiffness from short-term tachycardia-induced cardiodepression and angiotensin II. Circ Res (1998) 0.83
Instantaneous force-velocity-length relations: experimental findings and clinical correlates. Am J Cardiol (1977) 0.83
Spontaneous histamine secretion during isolation of rat cardiac mast cells. Inflamm Res (2004) 0.83
Myocardial fibrosis in the rat with mineralocorticoid excess. Prevention of scarring by amiloride. Am J Hypertens (1993) 0.83
Extracellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblast cells. J Cell Physiol (1996) 0.83
Rat cardiac mast cell maturation and differentiation following acute ventricular volume overload. Inflamm Res (2006) 0.83
Equations for the calculation of mean ejection pressure. Cardiovasc Res (1973) 0.82
Left ventricular systolic dynamics in terms of its chamber mechanical properties. Am J Physiol (1983) 0.82
Instantaneous force-velocity-length relations in isolated dog heart. Am J Physiol (1977) 0.82
Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulating hormones. Basic Res Cardiol (1991) 0.81
Determinants of stroke volume in the isolated canine heart. J Appl Physiol (1974) 0.81
Ejection pressure and the diastolic left ventricular pressure-volume relation. Am J Physiol (1977) 0.80
End-systolic relations: their usefulness and limitations in assessing left ventricular contractile state. Int J Cardiol (1984) 0.80
Flow-pulse response: a new method for the characterization of ventricular mechanics. Am J Physiol (1979) 0.80
Evolving role of cardiopulmonary exercise testing in cardiovascular disease. Clin Chest Med (1994) 0.80
Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure. J Am Coll Cardiol (1984) 0.80
Myocardial collagen and mechanics after preventing hypertrophy in hypertensive rats. Am J Hypertens (1989) 0.80
Cardiopulmonary exercise testing in clinical practice. Cardiology (1987) 0.80
Long-term oral enoximone therapy in chronic cardiac failure. Am J Cardiol (1987) 0.79
Cardioreparation with lisinopril in the management of hypertension and heart failure. Cardiology (1991) 0.79
Quantitative histology of the hypertrophied human heart. Fed Proc (1981) 0.79
Coronary microvascular fluid flux and permeability: influence of angiotensin II, aldosterone, and acute arterial hypertension. J Lab Clin Med (1993) 0.79
ANG II-related myocardial damage: role of cardiac sympathetic catecholamines and beta-receptor regulation. Am J Physiol (1998) 0.79
Dynamic anisotropic viscoelastic properties of the aorta in living dogs. Circ Res (1973) 0.79
Factors influencing the diastolic pressure-volume relation of the cardiac ventricles. Fed Proc (1980) 0.79